Factor XIa dimer in the activation of factor IX

被引:11
作者
Sinha, D
Marcinkiewicz, M
Lear, JD
Walsh, PN
机构
[1] Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Dept Biochem, Philadelphia, PA 19140 USA
[2] Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Dept Med, Philadelphia, PA 19140 USA
[3] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA
关键词
D O I
10.1021/bi050361x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Factor XI, unlike other coagulation proteins, is a homodimer of two identical subunits linked by a single disulfide bond formed by Cys321. The present study was undertaken to understand the physiological significance of the dimeric nature of factor XI. We have expressed a mutant FXI/G326C in which the Gly326 residue of factor XI has been mutated to Cys326, reasoning that Cys321 would form an intrachain disulfide bond with Cys326 as in prekallikrein, a plasma protein that exists as a monomer even with 58% amino acid sequence identity and a domain structure very similar to factor XI. No free thiol could be detected in the expressed protein, and it migrated as a monomer on nonreduced SDS-PAGE. In physiological buffer, however, the protein was found to exist in a state of monomer-dimer equilibrium as assessed by gel-filtration chromatography and ultracentrifugation studies (K-d similar to 36 nM). Functional studies revealed that FXI/G326C was indistinguishable from plasma factor XI in a plasma-clotting assay and in a factor IX activation assay both in the presence and absence of activated platelets even at concentrations at which less than 5% of the mutant exists as dimers. We conclude that, for optimal function in the presence of activated platelets, a preformed dimer of factor XI is not required.
引用
收藏
页码:10416 / 10422
页数:7
相关论文
共 26 条
[1]   IDENTIFICATION AND CHARACTERIZATION OF A BINDING-SITE FOR PLATELETS IN THE APPLE-3 DOMAIN OF COAGULATION-FACTOR-XI [J].
BAGLIA, FA ;
JAMESON, BA ;
WALSH, PN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (12) :6734-6740
[2]  
BOCK PE, 1983, J BIOL CHEM, V258, P5079
[3]   HUMAN-PLASMA PREKALLIKREIN, A ZYMOGEN TO A SERINE PROTEASE THAT CONTAINS 4 TANDEM REPEATS [J].
CHUNG, DW ;
FUJIKAWA, K ;
MCMULLEN, BA ;
DAVIE, EW .
BIOCHEMISTRY, 1986, 25 (09) :2410-2417
[4]   Molecular weights of CTLA-4 and CD80 by sedimentation equilibrium ultracentrifugation [J].
Fairman, R ;
Fenderson, W ;
Hail, ME ;
Wu, YL ;
Shaw, SY .
ANALYTICAL BIOCHEMISTRY, 1999, 270 (02) :286-295
[5]   AMINO-ACID-SEQUENCE OF HUMAN FACTOR-XI, A BLOOD-COAGULATION FACTOR WITH 4 TANDEM REPEATS THAT ARE HIGHLY HOMOLOGOUS WITH PLASMA PREKALLIKREIN [J].
FUJIKAWA, K ;
CHUNG, DW ;
HENDRICKSON, LE ;
DAVIE, EW .
BIOCHEMISTRY, 1986, 25 (09) :2417-2424
[6]   FACTOR-XI ACTIVATION IN A REVISED MODEL OF BLOOD-COAGULATION [J].
GAILANI, D ;
BROZE, GJ .
SCIENCE, 1991, 253 (5022) :909-912
[7]   Model for a factor IX activation complex on blood platelets: dimeric conformation of factor IXa is essential [J].
Gailani, D ;
Ho, D ;
Sun, MF ;
Cheng, QF ;
Walsh, PN .
BLOOD, 2001, 97 (10) :3117-3122
[8]   A comparison of murine and human factor XI [J].
Gailani, D ;
Sun, MF ;
Sun, YH .
BLOOD, 1997, 90 (03) :1055-1064
[9]  
GAILANI D, 2001, METABOLIC MOL BASIS, P4433
[10]   IDENTIFICATION OF 2 NOVEL MUTATIONS IN NON-JEWISH FACTOR-XI DEFICIENCY [J].
IMANAKA, Y ;
LAL, K ;
NISHIMURA, T ;
BOLTONMAGGS, PHB ;
TUDDENHAM, EGD ;
MCVEY, JH .
BRITISH JOURNAL OF HAEMATOLOGY, 1995, 90 (04) :916-920